This map shows the geographic impact of A E Pegg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A E Pegg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A E Pegg more than expected).
This network shows the impact of papers produced by A E Pegg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A E Pegg. The network helps show where A E Pegg may publish in the future.
Co-authorship network of co-authors of A E Pegg
This figure shows the co-authorship network connecting the top 25 collaborators of A E Pegg.
A scholar is included among the top collaborators of A E Pegg based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with A E Pegg. A E Pegg is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
9 of 9 papers shown
1.
Kokkinakis, Demetrius M., Dora Bocangel, S. Clifford Schold, R C Moschel, & A E Pegg. (2001). Thresholds of O6-alkylguanine-DNA alkyltransferase which confer significant resistance of human glial tumor xenografts to treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea or temozolomide.. PubMed. 7(2). 421–8.72 indexed citations
2.
Elion, Gertrude B., Peter J. Houghton, Stephen T. Keir, et al.. (2000). Schedule-dependent activity of temozolomide plus CPT-11 against a human central nervous system tumor-derived xenograft.. PubMed. 6(10). 4154–7.56 indexed citations
3.
Gerson, S L, et al.. (1999). Leukocyte O6-alkylguanine-DNA alkyltransferase from human donors is uniformly sensitive to O6-benzylguanine.. PubMed. 5(3). 521–4.7 indexed citations
Loktionova, Natalia A. & A E Pegg. (1996). Point mutations in human O6-alkylguanine-DNA alkyltransferase prevent the sensitization by O6-benzylguanine to killing by N,N'-bis (2-chloroethyl)-N-nitrosourea.. PubMed. 56(7). 1578–83.34 indexed citations
6.
Friedman, Henry S., M E Dolan, A E Pegg, et al.. (1995). Activity of temozolomide in the treatment of central nervous system tumor xenografts.. PubMed. 55(13). 2853–7.124 indexed citations
7.
Pegg, A E, et al.. (1993). A single amino acid change in human O6-alkylguanine-DNA alkyltransferase decreasing sensitivity to inactivation by O6-benzylguanine.. PubMed. 53(20). 4750–3.60 indexed citations
8.
Dolan, M. Eileen, et al.. (1991). Effect of O6-benzylguanine analogues on sensitivity of human tumor cells to the cytotoxic effects of alkylating agents.. PubMed. 51(13). 3367–72.199 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.